Loading organizations...
Loading organizations...
Enhancing access to orphan drugs for rare diseases in Europe.
Avanzanite Bioscience has raised $37.1M across 1 funding round.
Avanzanite Bioscience has raised $37.1M in total across 1 funding round.
Avanzanite Bioscience has raised $37.1M in total across 1 funding round.
Avanzanite Bioscience's investors include Jack Tanaka.
Avanzanite Bioscience has raised $37.1M across 1 funding round. Most recently, it raised $37.1M Series A in November 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 18, 2025 | $37.1M Series A | Jack Tanaka |